ArticleBreast cancer research : BCR2025

Serum metabolomic profiling for predicting therapeutic response and toxicity in breast cancer neoadjuvant chemotherapy: a retrospective longitudinal study.

Zhihao Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.